癌症免疫治疗中的时间动态:昼夜节律,瘤微环境和免疫检查点阻塞之间的相互作用
Anqi Lin1, Xiuhui Fang1, Pengpeng Zhang2
1Department of Oncology, Zhujiang Hospital, School of Stomatology, Southern Medical University, Guangzhou, China.
Journal of the National Cancer Center
|February 25, 2026
概括
循环节律通过调节瘤微环境 (TME) 和免疫检查点抑制剂 (ICI) 疗法的有效性,显著影响癌症. 优化癌症治疗包括定时药物输送和准TME动态.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 时间生物学 时间生物学
背景情况:
- 瘤微环境 (TME) 对癌症的进展和治疗反应至关重要.
- 昼夜节律影响TME组件和免疫检查点抑制剂 (ICI) 疗效.
研究的目的:
- 审查昼夜节律如何调节TME并影响ICI治疗.
- 提出基于昼夜节律和TME特征的优化癌症免疫疗法的策略.
主要方法:
- 对昼夜节律和TME组件之间的多层监管机制的系统审查.
- 对TME对ICI治疗疗效的影响分析.
- 确定ICI治疗优化策略.
主要成果:
- 循环节律调节瘤细胞特征,免疫细胞功能,血管新生和纤维细胞活动.
- TME通过免疫抑制,免疫检查点表达,T细胞功能和药物生物可用性影响ICI的疗效.
- 昼夜节律对于免疫检查点表达,免疫细胞功能,药物药理动力学和TME恒温至关重要.
结论:
- 昼夜节律在癌症免疫治疗中起着核心作用.
- 通过慢性治疗和TME向优化ICI治疗具有显著的临床潜力.
- 未来的研究方向包括人工智能驱动的时代医学和针对个性化癌症治疗的多omics分析.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
423
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
423
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Circadian Rhythms and Gene Regulation
4.6K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.6K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K


